4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001872873-25-000002
PRESIDENT AND CEO gave up 27,406 shares (to pay taxes)
- PRESIDENT AND CEO acquired 69,641 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise | +6,758 | 5,321,175 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Shares withheld for taxes | −2,660 | $5.53 | $14,710 | 5,318,515 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise | +11,781 | 5,330,296 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Shares withheld for taxes | −4,636 | $5.53 | $25,637 | 5,325,660 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise | +22,100 | 5,347,760 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Shares withheld for taxes | −8,697 | $5.53 | $48,094 | 5,339,063 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise | +29,002 | 5,368,065 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Shares withheld for taxes | −11,413 | $5.53 | $63,114 | 5,356,652 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise · Restricted Stock Units | −6,758 | 4,514 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise · Restricted Stock Units | −11,781 | 62,837 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise · Restricted Stock Units | −22,100 | 206,273 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-11-18 | Option exercise · Restricted Stock Units | −29,002 | 386,699 | D | ||
Loading xslF345X05/form4-11202025_111154.xml…